...
首页> 外文期刊>Clinical & developmental immunology. >Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting Shigella spp. Serine Protease Autotransporter Subfamily Protein SigA
【24h】

Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting Shigella spp. Serine Protease Autotransporter Subfamily Protein SigA

机译:以志贺氏菌为靶标设计潜在肽疫苗的疫苗组学方法。丝氨酸蛋白酶自转运蛋白亚家族蛋白

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Shigellosis, a bacillary dysentery, is closely associated with diarrhoea in human and causes infection of 165 million people worldwide per year. Casein-degrading serine protease autotransporter of enterobacteriaceae (SPATE) subfamily protein SigA, an outer membrane protein, exerts both cytopathic and enterotoxic effects especially cytopathic to human epithelial cell type-2 (HEp-2) and is shown to be highly immunogenic. In the present study, we have tried to impose the vaccinomics approach for designing a common peptide vaccine candidate against the immunogenic SigA of Shigella spp. At first, 44 SigA proteins from different variants of S. flexneri , S. dysenteriae , S. boydii , and S. sonnei were assessed to find the most antigenic protein. We retrieved 12 peptides based on the highest score for human leukocyte antigen (HLA) supertypes analysed by NetCTL. Initially, these peptides were assessed for the affinity with MHC class I and class II alleles, and four potential core epitopes VTARAGLGY, FHTVTVNTL, HTTWTLTGY, and IELAGTLTL were selected. From these, FHTVTVNTL and IELAGTLTL peptides were shown to have 100% conservancy. Finally, IELAGTLTL was shown to have the highest population coverage (83.86%) among the whole world population. In vivo study of the proposed epitope might contribute to the development of functional and unique widespread vaccine, which might be an operative alleyway to thwart dysentery from the world.
机译:痢疾志贺氏菌是一种细菌性痢疾,与人的腹泻密切相关,每年导致全世界1.65亿人感染。肠杆菌科(SPATE)亚家族蛋白SigA的酪蛋白降解丝氨酸蛋白酶自转运蛋白是一种外膜蛋白,对人上皮2型细胞(HEp-2)具有细胞毒性和肠毒性作用,尤其是细胞毒性,并且被证明具有高度免疫原性。在本研究中,我们试图强加疫苗学方法来设计针对志贺氏菌的免疫原性SigA的通用肽疫苗候选者。首先,评估了来自弗氏链球菌,痢疾链球菌,博伊氏链球菌和索内链球菌的不同变体的44个SigA蛋白,以找到最具抗原性的蛋白。我们根据NetCTL分析的人类白细胞抗原(HLA)超型的最高评分检索了12种肽。最初,评估这些肽与MHC I类和II类等位基因的亲和力,并选择了四个潜在的核心表位VTARAGLGY,FHTVTVNTL,HTTWTLTGY和IELAGTLTL。从中可以看出,FHTVTVNTL和IELAGTLTL肽具有100%的保守性。最后,IELAGTLTL被证明是全球人口最高的覆盖率(83.86%)。拟议表位的体内研究可能有助于开发功能性且独特的广泛疫苗,这可能是阻止来自世界各地的痢疾的有效途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号